Canada · Health Canada Drug Product Database

GLYCOPYRRONIUM / FORMOTEROL FUMARATE DIHYDRATE PRESSURIZED INHALATION SUSPENSION

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 96301
DIN: 02473615
Form: Aerosol (Metered-Dose)
Company as listed by source: ASTRAZENECA CANADA INC
Source status: Approved (2022-02-16)
Source last updated: 2025-03-22

Source-listed ingredients

GLYCOPYRRONIUM (GLYCOPYRROLATE) — 8.3 MCG — per 1 ACT
FORMOTEROL FUMARATE DIHYDRATE — 5.8 MCG — per 1 ACT

These values do not establish equivalence or a dose recommendation.

Packages

120 Act

Source and coverage

Open Health Canada Drug Product Database →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →